Literature DB >> 2436249

Effect of lithium administration on rat brain 5-hydroxyindole levels in a possible animal model for mania.

A L Vale, F Ratcliffe.   

Abstract

The effect of short term administration of lithium on the hyperactivity induced by a mixture of d-amphetamine (DEX) and chlordiazepoxide (CDZP) have been examined in the rat and an attempt made to relate this action to changes in brain concentrations of 5-hydroxytryptamine (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA). The DEX-CDZP mixture caused a large increase in Y-maze entries (P less than 0.001). Lithium (2 or 4 mEq/kg) attenuated the increase in entries (P less than 0.001) and activity cage locomotion (P less than 0.01) without significantly affecting these parameters in saline-treated rats. However, the increased 5-HT concentration (P less than 0.05) found in the midbrain after the DEX-CDZP mixture was not modified by prior administration of lithium. In control rats lithium had no effect on the level of 5-HT in the cerebellum, cerebral cortex, midbrain or striatum. Levels of 5-hydroxyindoleacetic acid (5-HIAA) in all four brain regions were unaffected by both the DEX-CDZP mixture or pretreatment with lithium. The possible action of the DEX-CDZP mixture on central 5-HT systems and the suitability of the hyperactivity induced by the drug mixture as a model for mania is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2436249     DOI: 10.1007/bf00518190

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  23 in total

1.  NORMOTHYMOTICS, "MOOD-NORMALIZERS": ARE LITHIUM AND THE IMIPRAMINE DRUGS SPECIFIC FOR AFFECTIVE DISORDERS?

Authors:  M SCHOU
Journal:  Br J Psychiatry       Date:  1963-11       Impact factor: 9.319

2.  Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.

Authors:  J C Barnes; B Costall; A M Domeney; R J Naylor
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Relationship between serum lithium level and clinical response in acute mania treated with lithium.

Authors:  R F Prien; E M Caffey; C J Klett
Journal:  Br J Psychiatry       Date:  1972-04       Impact factor: 9.319

4.  Effect of lithium on content and uptake of norepinephrine and 5-hydroxytryptamine in mouse brain synaptosomes and mitochondria.

Authors:  K Kuriyama; R Speken
Journal:  Life Sci I       Date:  1970-11-01

5.  Stimulation of serotonin synthesis by lithium.

Authors:  J Perez-Cruet; A Tagliamonte; P Tagliamonte; G L Gessa
Journal:  J Pharmacol Exp Ther       Date:  1971-08       Impact factor: 4.030

6.  Lithium and alpha-methyl-p-tyrosine prevent "manic" activity in rodents.

Authors:  C Davies; D J Sanger; H Steinberg; M Tomkiewicz; D C U'Prichard
Journal:  Psychopharmacologia       Date:  1974-04-23

7.  Combined effects of chlordiazepoxide and dexamphetamine on activity of rats in an unfamiliar environment.

Authors:  R Rushton; H Steinberg
Journal:  Nature       Date:  1966-09-17       Impact factor: 49.962

8.  Effects of lithium chloride on parameters biosynthetic capacity for 5-hydroxytryptamin in rat brain.

Authors:  S Knapp; A J Mandell
Journal:  J Pharmacol Exp Ther       Date:  1975-06       Impact factor: 4.030

9.  Lithium and amphetamine hyperactivity in rats. Differential effect on d and l isomers?

Authors:  A Flemenbaum
Journal:  Neuropsychobiology       Date:  1975       Impact factor: 2.328

10.  Effects of repeated lithium administration on the subcellular distribution of 5-hydroxytryptamine in rat brain.

Authors:  C K Atterwill; A F Tordoff
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

View more
  5 in total

1.  Structure-guided design of a highly selective glycogen synthase kinase-3β inhibitor: a superior neuroprotective pyrazolone showing antimania effects.

Authors:  Wenwen Chen; Irina N Gaisina; Hendra Gunosewoyo; Sam A Malekiani; Taleen Hanania; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2011-07-12       Impact factor: 3.466

2.  Identification of a glycogen synthase kinase-3β inhibitor that attenuates hyperactivity in CLOCK mutant mice.

Authors:  Alan P Kozikowski; Hendra Gunosewoyo; Songpo Guo; Irina N Gaisina; Richard L Walter; Ariel Ketcherside; Colleen A McClung; Andrew D Mesecar; Barbara Caldarone
Journal:  ChemMedChem       Date:  2011-07-05       Impact factor: 3.466

3.  Early life stress exacerbates cognitive dysfunction induced by d-amphetamine: amelioration by valproic acid.

Authors:  Rose Mary Carvalho Pinheiro; Maria Noêmia Martins de Lima; Gabriel Rodrigo Fries; Vanessa Athaíde Garcia; Juliana Presti-Torres; Luis Henrique Hallmenschlager; Luisa Azambuja Alcalde; Rafael Roesler; Monica Levy Andersen; João Quevedo; Flávio Kapczinski; Nadja Schröder
Journal:  J Neural Transm (Vienna)       Date:  2012-01-05       Impact factor: 3.575

Review 4.  Lithium and serotonin function: implications for the serotonin hypothesis of depression.

Authors:  L H Price; D S Charney; P L Delgado; G R Heninger
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior.

Authors:  Jared W Young; Andrew K L Goey; Arpi Minassian; William Perry; Martin P Paulus; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2009-12-18       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.